The products and information provided on this website are intended for healthcare professionals. These products are not for sale or distribution in the United States and statements made regarding these products have not been evaluated by the U.S. Food and Drug Administration (FDA). The efficacy of these products has not been confirmed by FDA-approved research and these products are therefore not intended to diagnose, treat, cure or prevent any disease. All information presented here is for general information purposes only and not meant as a substitute for or alternative to advice from healthcare practitioners. The Federal Food, Drug and Cosmetic Act requires this notice.
Neither the Company nor its representatives is providing any medical advice, and none should be inferred, from any ideas, suggestions, testimonials or other information set forth on this website or in other Company materials or provided over the phone, in the mail, in product packaging, or in email correspondence. This website may contain links to third-party websites. The Company provides these links as a convenience only and does not endorse any of these sites. The Company is not responsible for the content of, and does not make any representations regarding the materials on, such linked third-party websites. If you decide to access or rely on information at linked third-party website, you do so at our own risk. Our terms and conditions, including disclaimers, are more fully set forth in our Terms of Use, Privacy Policy and Terms of Online Sales.
Freiburger Symposium zum Thema „Extracorporeal Life Support“
Das dritte „Freiburger Symposium on Extracorporeal Life Support“ (FELS) findet am Freitag, dem 20. Mai 2022 im Kreativpark Lokhalle statt. In drei Sessions mit unterschiedlichen Themenschwerpunkten diskutieren internationale Experten die klinische Anwendung und die jüngsten Fortschritte in der extrakorporalen Zirkulation und Lungenunterstützung.
Das Programm gliedert sich wie folgt:
Session 1
Beginn: 09:00 Uhr
Themen: MCS in cardiogenic shock
Left ventricular unloading in V-A ECMO
Should there be an age limit for patients on ECMO?
Moderator: Dawid Staudacher
Podiumsgäste: Susann Price, London
Dirk Westermann, Freiburg
Justyna Swol, Nürnberg
Session 2
Beginn: 11:15 Uhr
Themen: ECPR for patients with out-of-hospital cardiac arrest
Out-of-center initiation of ECMO
Should ECMO be offered in every hospital?
Moderator: Tobias Wengenmayer
Podiumsgäste: Fabio Silvio Taccone, Brüssel
Jan Bělohlávek, Prag
Georg Trummer, Freiburg
Lunch Symposium
Beginn: 12:45 Uhr
Offene Diskussion mit den Podiumsgästen
Posterausstellung
Session 3
Beginn: 14:15 Uhr
Themen: The role of V-V-ECMO in the treatment of ARDS
Mechanical ventilation during V-V-ECMO
Weaning from V-V-ECMO
Moderator: Alexander Supady
Podiumsgäste: Daniel Brodie, New York (virtuell zugeschaltet)